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SUMMARY
Objective—Estimate annual incidence rates (IRs) of hip symptoms and three osteoarthritis (OA) 
outcomes (radiographic, symptomatic, and severe radiographic) overall and by race, 
sociodemographic characteristics, and hip OA risk factors.
Design—Analyze baseline (1991–1997) and first follow-up (1999–2003) data (n = 1446) from 
the Johnston County Osteoarthritis Project, a population-based, prospective study of adults ≥45 
years in North Carolina. Hip symptoms were pain, aching, and/or stiffness on most days, or groin 
pain. Radiographic and severe radiographic OA were Kellgren–Lawrence (KL) grades ≥2 and ≥3, 
respectively. Symptomatic OA was radiographic OA with symptoms in the same hip. 
Sociodemographics were age, gender, race, highest attained education, and annual household 
income. Hip OA risk factors were self-reported body mass index (BMI) at age 18 years, clinically 
measured BMI at baseline, and history of hip injury.
Results—Annual IRs (median = 5.5 years follow-up) were 37, 23, 13, and 2.9 per 1000 person-
years for hip symptoms, and radiographic, symptomatic, and severe radiographic hip OA, 
respectively. We found low IRs of radiographic and symptomatic hip OA among African 
Americans and high IRs of hip symptoms among the obese and the very poor. Across outcomes, 
IRs were highest for those with hip injury.
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Conclusion—No prior studies have reported IRs of hip symptoms; IRs of radiographic and 
severe radiographic hip OA were similar to, and the IR of symptomatic hip OA was higher than, 
previous estimates. Prevention efforts should target low socioeconomic status (SES) populations 
and obese adults; interventions for hip OA and hip symptoms are imperative for those with hip 
injuries.
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Hip osteoarthritis; Hip symptoms; Race; Socioeconomic status; Incidence rates
Introduction
Hip osteoarthritis (OA) is a common cause of pain and disability among older adults and a 
predominant reason for total hip replacement (THR) surgery1, which, in the US, is expected 
to grow to half a million procedures annually by 20302. Among adults aged ≥45 years, 
radiographic hip OA affects 27%, and symptomatic hip OA (defined as radiographic OA 
with hip symptoms) may affect 3–9%3,4. Hip pain and other OA symptoms can substantially 
impair health and functioning, limit daily activities and reduce quality of life5,6, and can 
significantly affect individuals financially through lost wages and need for informal care7,8. 
Additionally, hip OA has been associated with an increased risk of mortality among older 
women9. These costs and the poor health associated with hip OA are part of a global public 
health problem that is predicted to only worsen10.
Epidemiological studies of incident hip OA have examined the role of demographics 
(women, older age, and white/African American race)11–15 and modifiable risk factors (hip 
injury and obesity)11,16–25, but most of these studies have reported ratio measures (e.g., odds 
ratios). Descriptive studies quantifying the incidence rate (IR) – the rate at which new cases 
arise in the population – provide data that can be used for projecting prevalence and 
forecasting health service utilization and costs. Further, hip pain and symptoms can have a 
substantial health and economic impact, but no studies have reported IRs of hip pain/
symptoms independently of radiographic hip OA, which can be poorly correlated with 
symptoms5,6,26.
Of the few studies that have reported IRs of hip OA, some were in limited populations (e.g., 
white race or women only) and others reported only cumulative incidences27, which may not 
adequately account for variation in observation time among participants. Furthermore, some 
US studies were conducted several decades ago and may not represent IRs in current 
populations given aging, increasing racial/ethnic diversity, and increasing prevalence of 
obesity in the US over past decades. Of the previous studies, two in the US estimated IRs for 
symptomatic hip OA from health records; Wilson et al. estimated an age and sex-adjusted 
rate of 47 per 100,000 person-years for the entire population of Rochester, MN in 198512, 
and Oliveria et al. estimated an age and sex-adjusted rate of 88 per 100,000 person-years 
among HMO members aged 20–89 in Worcester County, MA between 1998–199211. Three 
studies reported cumulative incidence of radiographic OA; from the Study of Osteoporotic 
Fractures, a multicenter US cohort of Caucasian women ≥65 years (mean follow-up 8 years), 
Lane et al. found 33% and 14% developed radiographic and severe radiographic OA (KL 
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≥3) respectively of the hip between 1986–199828; from the Rotterdam Study, a population-
based Dutch cohort aged ≥55 (mean follow-up 6.6 years), Reijman et al. estimated 17% 
developed incident radiographic hip OA as defined by Kellgren–Lawrence (KL) grade ≥2, 
between 1990–199929; from the Johnston County OA Project (JoCo OA), Kopec et al. 
reported that radiographic OA developed in 7% of hips (joint-based analysis)13. Grotle et al. 
estimated 10-year cumulative incidence of self-reported hip OA of 6% in a population-based 
cohort ages 24–76 years in Ullensaker, Norway in 1994–2004.
Given these limited data on IRs of hip OA-related outcomes, we conducted a comprehensive 
hip OA incidence study using data from the JoCo OA, a large population-based, prospective 
cohort study in Johnston County, North Carolina. The purpose of this study was to quantify 
annual IRs of hip symptoms and three types of hip OA (radiographic, symptomatic, and 
severe radiographic hip OA). For three outcomes (hip symptoms, radiographic, symptomatic 
hip OA), we estimated overall IRs among African Americans and whites. For these three 
outcomes, we also estimated IRs by selected sociodemographic variables and hip OA risk 
factors, overall and for each race. Annual IRs for subgroups can be used to prioritize 
susceptible populations for further research and prevention efforts.
Method
We analyzed baseline (1991–1997) and first follow-up (1999–2003) data from the JoCo OA. 
The study’s overall methodological approach is detailed elsewhere30. Enrolled participants 
represented civilian, non-institutionalized African Americans and whites ≥45 years who 
were residents of one of six designated townships in Johnston County for at least 1 year and 
who were physically and mentally capable of study completion. At both baseline and first 
follow-up, participants completed two in-home interviews, approximately 2 weeks apart, and 
a clinical examination. Supine anterior–posterior pelvis radiographs for both hips were read 
using standard Kellgren–Lawrence (KL) grade (0–4)31. Pelvic radiographs were not 
obtained from women <50 years. The institutional review boards of the Centers for Disease 
Control and Prevention and the University of North Carolina Schools of Medicine and 
Public Health approved the study’s protocol.
JoCo OA staff employed various methods to minimize attrition between baseline and first 
follow-up. Staff used annual newsletters, personal networks, local advertising, medical 
providers, and community inquiries to locate and retain participants. Deaths were identified 
through multiple sources including local obituaries, word-of-mouth, local and North 
Carolina death records, and the National Death Index (NDI), the most complete source of 
mortality data.
Measurement of hip symptoms and hip OA outcomes
Annual IRs were estimated for hip symptoms and three types of hip OA (radiographic, 
symptomatic, and severe radiographic hip OA). Hip symptoms were defined as either a 
“yes” to the question “On most days, do you have pain, aching, or stiffness in your (right, 
left) hip?” or reported the presence of (right, left) groin pain. Radiographic and severe 
radiographic OA were defined as KL grades of ≥2 and ≥3, respectively. Inflammatory 
arthritis occurred in 21 participants; joints with radiographic evidence of inflammatory 
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arthritis were treated as having missing KL grades and thereby excluded from analysis. 
Symptomatic OA was defined as having radiographic OA and hip symptoms in the same hip. 
Because symptomatic OA is the underlying cause in the majority of THRs1, those with THR 
were classified as affected for all four outcomes, similar to previous studies13,32.
For each outcome, an incident case was a participant who was not affected at baseline who 
developed the outcome in at least one hip by first follow-up (range 3–13 years). Baseline 
prevalent cases (i.e., participants having a given outcome in one or both hips at baseline) 
were excluded from analysis of that outcome, and therefore the number of participants 
varied for each outcome analysis (Table I). Analyses for hip symptoms included participants 
aged ≥45 years. Because women of reproductive age (<50 years) (n = 312) did not have hip 
radiographs, we also excluded men <50 years (n = 175) (Table I) so that the three hip OA 
outcome analyses comprised the same age groups for women and men.
Sociodemographic and hip OA risk factors
Sociodemographic characteristics (and their categorized levels) analyzed were age (45–54 or 
50–54 [as appropriate], 55–64, 65–74, and ≥75 years), sex (men, women), race (African 
American, white), highest attained education (<high school [<grade 12], some/completed 
high school [grade 12/GED {general equivalency diploma}], >high school [college/grad 
school] and annual household income ($0–<15,000, $15,000–<35,000, ≥$35,000). The three 
hip OA risk factors were self-reported body mass index (BMI) in kg/m2 at age 18 (under/
healthy weight [<25], overweight/obese [≥25]) and clinically measured BMI at baseline 
(under/healthy weight [<25], overweight [25–<30], and obese [≥30] {Class I [30–<35] and 
Class II–IV [≥35]}), and history of hip injury (yes, no). Self-reported BMI at age 18 was 
based on participants’ report of their weight at age 18. The denominator for all BMI 
calculations was clinically measured height at baseline. Hip injury was ascertained during 
the baseline clinic examination with “Have you ever injured your (right, left) hip?”.
Statistical analysis
Using person as the unit of analysis, we estimated annual IRs using a Poisson model with an 
offset (a term incorporated into the model to compute rates) taken as the natural logarithm of 
participant observation time (in years) to accommodate the variation in follow-up time 
among participants. We computed a crude IR (overall and stratified by sociodemographics 
and hip OA risk factors described above) with 95% confidence intervals (CI). For overall 
IRs, we also computed age- and age- and sex-standardized IRs using the 2000 projected US 
population with the same age categories that we analyzed (45–54 or 50–54 [as appropriate], 
55–64, 65–74, and ≥75 years). We estimated race-specific IRs stratified by the same 
sociodemographics and hip OA risk factors using models that included race as an additional 
independent variable. We also tested for interactions with race but none was significant, 
most likely due to small sample sizes and low statistical power to detect these interactions. 
We did not compute stratified or race-specific IRs of severe radiographic hip OA because 
these estimates were unreliable due to the small number of unweighted cases (n = 30) (Table 
I).
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To account for the complex sampling design, observations were weighted with population-
calibrated sampling weights so that results are generalizable to the target Johnston County 
population. We calculated 95% CIs using jackknife methods that accounted for stratification 
and clustering in the sampling design with a finite population correction to adjust for 
sampling without replacement33,34. Jackknifing produces accurate CIs even in the presence 
of overdispersion (i.e., variance greater than predicted by a Poisson distribution). We tested 
for differences in IRs using a Wald test with jackknife variance estimates that accounted for 
the sampling design. For age, education, self-reported BMI at age 18, and clinically 
measured BMI at baseline, we also tested for a trend through assessing the slope in models 
that included each of these characteristics as a continuous variable. Statistical significance 
was determined using a Bonferroni-corrected alpha of 0.0166 (<0.05/3 outcomes) to adjust 
for multiple comparisons across three outcomes (hip symptoms, and radiographic and 
symptomatic hip OA, but not severe radiographic hip OA owing to its lack of formal 
comparisons)35. We performed statistical analyses with SAS version 9.3.
Sensitivity analysis
We performed sensitivity analyses for income imputation and selection bias following 
procedures detailed in Murphy et al.36. We conducted these analyses to determine the extent 
to which missing income data and selection bias due to attrition may have influenced the 
IRs.
Income imputation
Based on weighted percentages, income was unknown for 18% of participants due to 
nonresponse (“refused” or “don’t know”), so we repeated the IR analyses using imputed 
income values to assess bias due to missing data. We performed multiple imputation with 
baseline variables for sociodemographics, hip OA risk factors/outcomes, and characteristics 
associated with income or income nonresponse. We found that analyses based on imputed 
income data produced similar IRs to those presented here. Thus any bias due to missing 
income data was likely small.
Selection bias
Because approximately 48% of eligible participants were excluded from IR estimation 
(Table I), we performed additional analyses to evaluate the extent of selection bias in the 
overall estimates. We computed approximate IRs for the analytic and eligible baseline 
populations (Table II)36. For all outcomes we found that these approximate IRs were similar 
to each other. Thus differences between the analytic and baseline eligible populations 
appeared to have had little impact on IR estimates, and any potential selection bias was 
likely small.
Results
Of the 3068 participants in the JoCo OA sample at baseline, 2788 were potentially eligible 
for analysis after applying baseline exclusions (Table I). Of these 2788, about half (n = 
1446) had both baseline and follow-up data for at least 1 of the 4 outcomes and were 
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included in the analytic sample (Table I). The median follow-up time for analyzed 
participants was 5.5 years (3–13 years).
Based on weighted percentages, the analytic sample represented a population at baseline that 
was over half women (58%) and predominantly white (80%) having a median age of 55 
years (Table II). Most were married (73%) and had completed at least some high school 
(88%). About 25% had an annual household income under $15,000, 28% had an income of 
$35,000 or more, and income was unknown for 7% due to “don’t know” and 11% due to 
“refused” responses. At age 18, only 8% were overweight or obese whereas most were 
overweight (44%) or obese (25%) at the time of study baseline. Among those who were 
obese, almost a third were Class II–IV (BMI ≥35). Only 3% had a history of hip injury.
Crude and standardized annual IRs
Crude and standardized annual IRs are presented in Table III. Crude IRs per 1000 person-
years for hip symptoms, and radiographic, symptomatic, and severe radiographic hip OA 
were 37 (95% CI = 33, 41), 20 (95% CI = 18, 23), 13 (95% CI = 12, 16), and 2.9 (95% CI = 
2.3, 3.7), respectively. Age-standardized and age- and sex-standardized IRs were higher than 
crude estimates (Table III).
Stratified and race-specific IRs
Annual IRs stratified by sociodemographic characteristics and hip OA risk factors are 
presented in Table IV, and race-specific annual IRs are presented in Table V, for the three 
outcomes of hip symptoms, radiographic OA, and symptomatic OA. We presented overall 
and race-specific IRs by age group in Figure 1.
Sociodemographic characteristics
Race—Across the three outcomes, IRs were lower among African Americans with 
significant differences for radiographic and symptomatic OA. The IR of radiographic OA 
was 24/1000 person-years for whites and 7/1000 person-years for African Americans, just 
over a quarter the rate of whites. The IR of symptomatic OA was 15/1000 person-years for 
whites and 7/1000 person-years for African Americans, less than half the rate of whites 
(Table IV).
Age—Across the three outcomes, IRs increased with greater baseline age, and trends were 
significant for radiographic and symptomatic OA. The IR of radiographic OA more than 
doubled from 12 to 27/1000 person-years between ages 50–54 and 55–64 and then remained 
steady among older ages. The annual IR of symptomatic hip OA almost tripled from 8 to 
23/1000 person-years from youngest to oldest ages (Table IV, Fig. 1). Race-specific IRs for 
age showed similar trends (Table V, Fig. 1).
Sex—Across the three outcomes, IRs were higher among women than men with significant 
differences for hip symptoms and symptomatic OA, which were almost 50% higher among 
women (Table IV). Race-specific IRs for sex showed similar patterns (Table V).
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Highest education—For hip symptoms and radiographic OA, IRs decreased moderately 
with greater educational attainment with a significant trend only for radiographic OA (Table 
IV). The trend in race-specific IRs of radiographic OA was also significant; compared with 
the overall sample, the decreasing trend appeared stronger among whites but was attenuated 
among African Americans (Table V).
Annual household income—The annual IR of 45/1000 person-years of hip symptoms 
for those with lowest income was among the highest rates observed across all 
subpopulations that we analyzed (Table IV). Across all three outcomes, race-specific IRs 
decreased with rising income, but differences were significant only for hip symptoms (Table 
V).
Hip OA risk factors
Self-reported BMI at age 18: The IR of hip symptoms was moderately higher among those 
with greater BMI at age 18, but there was no significant trend. Conversely for symptomatic 
OA, the IR among those who were overweight/obese was less than half the IR among those 
who were under/normal weight at age 18, and though the difference was significant, there 
was no significant trend. Across the three outcomes, the IRs of radiographic OA varied little 
(Table IV). Race-specific IRs of BMI at age 18 showed similar patterns (Table V).
Clinically measured BMI at baseline: For hip symptoms, the IR increased significantly 
with greater BMI at baseline; the IR of 48/1000 person-years among obese persons (≥30) 
was high at twice the IR of 24/1000 person-years among under/healthy weight (<25) persons 
(Table IV). The IR of radiographic OA varied significantly across BMI levels but there was 
no significant trend. The IR of symptomatic OA varied little across BMI levels (Table IV). 
Race-specific IRs for BMI at baseline showed similar patterns (Table V).
History of hip injury: Across the three outcomes, those with hip injury had the highest IRs 
of all characteristics that we analyzed. Those with hip injury had higher IRs than those 
without hip injury, but these differences were not significant in the overall sample (Table 
IV). After stratifying by race, the difference was significant for symptomatic OA. Within 
each race, those with hip injury had double the IR of symptomatic OA (Table V).
Discussion
In this study of adults aged ≥45 years followed for a median of 5.5 years, IRs were 37, 20, 
13, and 2.9 per 1000 person-years for hip symptoms, and radiographic, symptomatic, and 
severe radiographic hip OA, respectively. Overall and across sociodemographic subgroups 
and hip OA risk factors, the IRs of radiographic and symptomatic hip OA among African 
Americans were significantly lower than IRs for whites. For both African Americans and 
whites, the highest IRs of hip symptoms occurred among those aged ≥75 years, those with 
an annual household income <$15,000, those who were obese, and those with history of hip 
injury. Those with hip injury also had highest IRs of radiographic and symptomatic hip OA, 
indicating the importance of OA prevention efforts among this subgroup.
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Previous studies have assessed hip OA incidence data by race, age, and sex. Our findings of 
lower IRs of radiographic and symptomatic hip OA among African Americans are consistent 
with a joint-based (as opposed to person-based) analysis of incident radiographic hip OA in 
the JoCo OA cohort13. Across outcomes, IRs increased with older age with significant 
trends for radiographic and symptomatic OA. Although this same pattern has been found 
with radiographic OA20,21, previous studies have shown declining IRs of incident 
symptomatic hip OA among the oldest ages11,12. Differences in study populations and small 
numbers of oldest participants12 likely contribute to variation in trends in oldest ages12. Also 
reported previously11,12,37, women had significantly higher IRs of hip symptoms and 
symptomatic hip OA than men.
This is among the first studies of socioeconomic status (SES) and hip OA, and it is the first 
study to quantify IRs of hip outcomes by household income and educational attainment. 
Lower education was associated with a higher IR of radiographic OA, and lowest income (<
$15,000) was associated with a higher IR of hip symptoms after adjusting for race. Two 
previous studies, one in the JoCo OA cohort, have also reported higher risk of hip OA 
among low SES populations38,39, but our IR data further showed that those with lowest 
income had among the highest rates of hip symptoms across the large number of 
subpopulations that we analyzed. Regardless of cause, high IRs among low-SES populations 
are a concern given the substantial economic costs due to OA-associated hip symptoms7 and 
the disproportionate impact those costs may have on low-income households. Therefore, 
public health initiatives that prioritize low-SES populations and promote low-cost, evidence-
based strategies (e.g., physical activity, weight loss, and self-management) are needed. 
Furthermore, conducting interventions and addressing barriers to uptake in low SES 
populations38 may be an effective means of lowering incidence of hip symptoms.
Adults with greater BMI at baseline had a significantly higher IR of hip symptoms with a 
strong positive trend. We found wide variation in IRs of radiographic OA, with lowest rates 
among overweight persons, but no significant trend. The IRs of symptomatic hip OA varied 
little across levels of BMI. Similarly discordant patterns have been reported previously19,40, 
and our findings for hip OA are consistent with studies reporting a lack of association with 
incident hip OA20–22,25,41. Given the strong positive association between BMI and hip 
symptoms and the very high IR of hip symptoms among obese, focusing prevention among 
overweight/obese adults and emphasizing strategies to maintain healthy weight may reduce 
incident hip symptoms.
We found that a high BMI at age 18 did not predict the development of incident hip OA 
among those aged ≥50 years. In fact, those who were overweight/obese at age 18 had a 
lower IR of symptomatic hip OA, and further we found no significant trend between BMI at 
age 18 and onset of any hip outcomes. Variation in estimates and lack of significance was 
also found for self-reported hip OA with clinically measured and self-reported BMI in a 
previous study among young men16. Characteristics that we did not analyze such as life-
course BMI42–45 and other population characteristics (e.g., sex, age, and BMI at baseline) 
may explain the patterns in IRs that we observed.
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Consistent with previous studies, hip injury was associated with a higher IR of symptomatic 
hip OA17,18,22,24 after adjusting for the effect of race. For the three hip outcomes, those with 
hip injury had highest IRs across all characteristics that we analyzed. Therefore targeted 
interventions for hip OA prevention and self-management may greatly benefit those with hip 
injuries.
Compared with previous studies, the overall IRs of radiographic and severe radiographic hip 
OA are consistent with annual rates reported previously27–29. We found no other studies 
reporting IRs of hip pain/symptoms to compare with IRs of hip symptoms. Our overall IR of 
symptomatic hip OA was substantially higher than previous IR estimates based on health 
records of inpatient and outpatient visits for clinical care11,12, which may be conservative 
since a majority of adults with joint pain do not seek care for their symptoms46,47. 
Differences in study population characteristics and OA definitions also likely contribute to 
differences in estimates.
This study has several limitations. First, similar to most longitudinal studies, the results are 
in a small geographic area and may have limited generalizability to other populations. 
Second, death and loss to follow-up are common for longitudinal studies in older 
populations, particularly with longer follow-up intervals as in this study, and attrition in the 
JoCo OA was not trivial. Although we determined that selection bias resulting from attrition 
was likely small, there remains the possibility that we may not have accounted for other 
types of bias potentially associated with attrition. Third, because we estimated incident hip 
symptoms and hip OA outcomes, relatively rare conditions, we had insufficient numbers of 
cases and low power to detect some effects (e.g., hip injury) and assess differential patterns 
of association (i.e., interactions) by race.
This study also has several important strengths. First, we conducted a comprehensive, 
descriptive analysis of incident hip outcomes from which we have presented IRs of four hip 
OA-related outcomes for a large population-based prospective study. We estimated IRs for 
African Americans and whites, and we identified dramatically lower IRs of hip OA for 
African Americans, overall and across all subpopulations that we analyzed. These 
population-based IRs provide relatively more recent data to improve projections of costs, 
prevalence, and demand for health services in increasingly diverse populations. Secondly, 
we estimated IRs of hip symptoms which can substantially impair health even in the absence 
of radiographic signs of hip OA5. Knowing these IRs can help clinicians and public health 
professionals recognize additional high risk groups for intervention opportunities to reduce 
and prevent hip symptoms. Thirdly, we quantified IRs overall and by numerous 
sociodemographic characteristics and hip OA risk factors. Quantifying IRs can identify 
subpopulations in which the prevalence and consequent burden of hip OA is growing most 
rapidly in addition to determining those at increased risk of hip OA-related outcomes.
The IRs we present provide valuable insights to clinicians and public health practitioners in 
their ongoing efforts to reduce the future impact of hip OA. In the JoCo OA cohort, the IR of 
hip symptoms was high, and, compared with earlier estimates, we found substantially higher 
IRs of symptomatic hip OA. The IRs of radiographic and severe radiographic hip OA were 
similar to previous estimates. African Americans had low IRs of radiographic and 
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symptomatic hip OA compared with whites. In addition to higher IRs among women (hip 
symptoms and symptomatic OA), oldest ages (radiographic and symptomatic OA), and those 
with hip injury (symptomatic OA), those with lower education had a higher IR of 
radiographic OA, and several of the highest IRs of hip symptoms occurred among those with 
lowest income and greatest BMI. Across outcomes, IRs were highest among those with a hip 
injury. Public health efforts should prioritize low-SES populations, obese adults, and those 
with a hip injury for further action and prevention of hip symptoms and hip OA.
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Fig. 1. 
Incidence rate (IR) per 1000 person-years for hip symptoms and OA outcomes by age group, 
overall and within each race.
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Table II
Weighted* distribution (%)† of baseline sociodemographic characteristics and hip OA risk factors for the 
analytic and eligible baseline samples
Analytic sample n = 1446 Eligible baseline sample n = 2778
Sociodemographic characteristics
Age (years)
 45–54 52 30
 55–64 26 29
 65–74 18 28
 ≥75 5 13
Median 55 62
Sex
 Men 42 43
 Women 58 57
Race
 African American 20 18
 White 80 82
Marital status
 Never married 4 3
 Married 73 66
 Separated/divorced 9 10
 Widowed 13 22
Highest education
 <High school 11 21
 Some/completed high school 54 52
 >High school 34 28
Annual household income
 $0–<$15,000 25 35
 $15,000–<$35,000 29 27
 ≥$35,000 28 17
 Don’t know 7 9
 Refused 11 12
Hip OA risk factors
Self-reported BMI at age 18 (kg/m2)
 Under or healthy weight (<25) 92 90
 Overweight or obese (≥25) 8 10
Clinically measured BMI at study baseline (kg/m2)
 Under or healthy weight (<25) 31 34
 Overweight (25–<30) 44 42
 Obese (≥30) 25 24
  Obese Class I (30–<35) 17 17
  Obese Class II–IV (≥35) 7 6
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Analytic sample n = 1446 Eligible baseline sample n = 2778
History of hip injury
  No 97 95
 Yes 3 5
*
The analytic and eligible samples were weighted to the Johnston County population in 2000 and 1990, respectively. Differences in weighted 
numbers are due to the use of different sampling weights applied to the baseline and follow-up samples.
†
Percentages may not sum to 100% due to rounding.
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